These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25376267)

  • 1. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
    Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
    Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
    Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
    Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis.
    Evans JD; Morris PJ; Knight SR
    Am J Transplant; 2014 Dec; 14(12):2765-76. PubMed ID: 25395336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
    Winston DJ; Pakrasi A; Busuttil RW
    Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
    Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W
    Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting antifungal prophylaxis in high-risk liver transplant recipients.
    Huprikar S
    Am J Transplant; 2014 Dec; 14(12):2683-4. PubMed ID: 25376442
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of anidulafungin in solid organ transplant recipients.
    Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
    Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
    Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS
    J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
    Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
    Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
    Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M
    Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of anidulafungin in solid organ transplant recipients].
    Aguado JM; Ayats J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
    Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
    San-Juan R; Aguado JM; Lumbreras C; Fortun J; Len O; Muñoz P; Montejo M; Moreno A; Cordero E; Blanes M; Ramos A; de la Torre-Cisneros J; Lopez-Medrano F; Carratala J; Moreno E;
    Transplantation; 2011 Aug; 92(3):346-50. PubMed ID: 21709604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.